Discover the full directors' dealings record of Medbox, Inc., a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 7 January 2016 (Attribution). Among the most active insiders: SIEGEL NED L. All data is accessible without an account.
15
Insider Decl.
0
Thresholds
·
7 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Medbox, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
19Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Medbox, Inc. is a NASDAQ-listed company that specializes in management solutions for the cannabis industry. It offers technologies and services to help businesses comply with regulations and optimize their operations.